icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
 
 
 
Renal Safety of Tenofovir Alafenamide in Patients at High Risk of Kidney Disease
 
 
  Reported by Jules Levin
CROI 206 Feb 22-24 Boston
 
David Wohl1, Anders Thalme2, Robert Finlayson3, Shinichi Oka4, Thai Nguyen5, Susan Guo5, Andrew Cheng5, Moupali Das5, Marshall Fordyce5
1University of North Carolina at Chapel Hill, USA; 2Karolinska University Hospital, Stockholm, Sweden; 3Taylor Square Private Clinic, NSW, Australia; 4National Center for Global Health and Medicine Hospital, Tokyo, Japan; 5Gilead Sciences, Inc., Foster City, CA, USA

CROI1

CROI2

CROI3

CROI4

CROI5

CROI6

CROI7

CROI8

CROI9